Related Experiment Video
Updated: Aug 19, 2026
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Intracranial complications of mucormycosis: an experimental model and clinical review
V K Anand1, G Alemar, J A Griswold
1Division of Otolaryngology, University of Mississippi Medical Center, Jackson 39216-4505.
Abstract:
The clinical course of patients with mucormycosis of the paranasal sinuses can be unpredictable and is often determined by intrinsic host factors. The degree to and mechanism(s) by which these factors influence a patient's ability to survive the disease are poorly understood. Extensions to orbital and intracranial structures occur in some patients with paranasal sinus mucormycosis despite aggressive treatment. Controversies persist over adequate antifungal regimen, the precise role of hyperbaric oxygenation, and the appropriate extent of surgical debridement. We have developed an alloxan-induced immunocompromised murine model of mucormycosis in mice. Deferoxamine iron chelation produced rhinocerebral mucormycosis in these animals when challenged intraethmoidally with Rhizopus spores. The implications of our experimental studies in the content of our clinical experience in managing patients with intracranial extensions of paranasal sinus mucormycosis are discussed.
Insights
This study explores mucormycosis in paranasal sinuses, a fungal infection with unpredictable outcomes. A new mouse model using deferoxamine helps understand host factors influencing survival and disease progression.
Area of Science:
- Mycology
- Infectious Diseases
- Immunology
Background:
- Mucormycosis of the paranasal sinuses presents unpredictable clinical courses.
- Host factors significantly influence patient survival but are poorly understood.
- Orbital and intracranial extensions occur despite aggressive treatment, highlighting treatment challenges.
Purpose of the Study:
- To investigate the mechanisms by which host factors affect survival in paranasal sinus mucormycosis.
- To develop and utilize a novel murine model for studying rhinocerebral mucormycosis.
- To correlate experimental findings with clinical management of intracranial extensions.
Main Methods:
- Development of an alloxan-induced immunocompromised murine model.
- Induction of rhinocerebral mucormycosis using deferoxamine iron chelation and intraethmoidal challenge with Rhizopus spores.
- Evaluation of host factors and disease progression in the experimental model.
Main Results:
- The developed murine model successfully replicated rhinocerebral mucormycosis.
- Deferoxamine-induced iron chelation was critical in establishing the infection in immunocompromised mice.
- The model provides insights into the pathogenesis and host-animal interactions in mucormycosis.
Conclusions:
- The study establishes a valuable murine model for investigating paranasal sinus mucormycosis.
- Understanding host factors is crucial for improving survival rates in patients with mucormycosis.
- Experimental data can inform clinical strategies for managing complex cases, including intracranial extensions.
